N
NVCR
Novocure
18.26
+0.30+1.67%After Hours: 18.18 -0.08 -0.41%18:27 05/26 EDT
OPEN/PREV CLOSE18.00/17.96
TODAY RANGE17.80-18.67
VOL1.93M
MARKET CAP2.11B
52 WEEK RANGE9.82-20.06
AVG VOL (3M)1.49M
% TURNOVER1.67%
TURNOVER--
P/E (TTM)-11.8996
% RANGE4.84%
EPS(TTM)-1.5345
P/E(FORWARD)-11.2716
P/B6.39
BVPS2.855
DIVIDEND--
P/S3.134
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.90B
SHARES OUTSTANDING115.82M
NEXT EARNINGS07/20-08/04
FREE FLOAT104.27M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·19h ago
Piper Sandler Reaffirms Their Buy Rating on NovoCure (NVCR)
TipRanks·05/20 05:25
NovoCure Earnings Call Highlights Growth, One-Time Hit
PUBT·05/19 12:06
Lifeward names Keith D. Rose chief medical officer
Simply Wall St·05/14 09:46
NovoCure (NVCR) Is Up 9.7% After Raising 2026 Revenue Outlook And Posting Stronger Q1 Sales
Simply Wall St·05/09 04:44
A Look At NovoCure (NVCR) Valuation After Raised 2026 Revenue Guidance And Q1 Beat
NASDAQ·05/05 13:05
3 Overlooked Stocks Set to Soar in 2026
Simply Wall St·05/04 20:21
Why NovoCure (NVCR) Is Up 33.2% After FDA Clears Optune Pax And Guidance Ticks Higher
Dow Jones·05/04 19:08
Novocure Is Maintained at Equal-Weight by Wells Fargo
Benzinga·05/04 18:57
Wells Fargo Maintains Equal-Weight on NovoCure, Raises Price Target to $17
NASDAQ·05/04 13:15
International Markets and NovoCure (NVCR): A Deep Dive for Investors
TipRanks·05/04 10:36
Novocure price target raised to $17 from $13.50 at Wells Fargo
Simply Wall St·05/02 09:44
NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook
Seeking Alpha·05/01 16:35
NovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer Yet
TipRanks·05/01 14:46
Wedbush Remains a Hold on NovoCure (NVCR)
Dow Jones·05/01 13:32
Novocure Is Maintained at Outperform by Evercore ISI Group